Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

35.18 -0.14 (-0.40%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
29 30 Next >
News headline image
Market Whales and Their Recent Bets on VKTX Options ↗
 
Via Benzinga
News headline image
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come? ↗
These three biotech stocks are leading the sector higher on upbeat news but is this as good as it gets or do they have more gas in the tank? 
Via InvestorPlace
News headline image
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Viking Therapeutics: Strong Results In Obesity ↗
With a potential best in class drug for oral and injectable use, Viking Therapeutics has to be on many Big Pharma/Bio acquisition wish lists, as the company represents a very scarce asset in the $100... 
Via Talk Markets
News headline image
3 Magnificent Stocks That Could Double or More by 2030 ↗
There's no guarantee these stocks will double by 2030, but their growth prospects look great. 
Via The Motley Fool
News headline image
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027 ↗
For investors looking for a way to play weight-loss stocks in this current backdrop, here are three top options to consider right now. 
Via InvestorPlace
News headline image
Viking Therapeutics's Options: A Look at What the Big Money is Thinking ↗
 
Via Benzinga
News headline image
Is it Too Late to Buy Viking Therapeutics Stock? ↗
Viking Therapeutics stock is on fire following a successful phase 2 trial for its obesity care candidate. 
Via The Motley Fool
News headline image
Viking Therapeutics Just Announced More Positive Results: Time to Buy? ↗
The drugmaker isn't losing momentum. 
Via The Motley Fool
News headline image
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names ↗
Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments. 
Via InvestorPlace
News headline image
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics ↗
These rising drugmakers have serious arguments in their favor. 
Via The Motley Fool
News headline image
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead. ↗
Viking Therapeutics has garnered a lot of attention following a successful clinical trial for its obesity care drug. But another development-stage biotech may have a superior candidate. 
Via The Motley Fool
News headline image
Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
Altimmune has a GLP-1 candidate in Phase 2 trials, but the company continues to burn cash and may need a big pharma partner to get its drug to market 
Via MarketBeat
News headline image
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It. ↗
Shares of the clinical-stage biotech have skyrocketed on recent good news. 
Via The Motley Fool
News headline image
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,900 Today ↗
 
Via Benzinga
News headline image
MarketBeat Week in Review – 4/1 - 4/5
Equities lost ground this week as investors consider the effect of fewer rate cuts, rising oil prices, and robust job gains ahead of a new earnings season 
Via MarketBeat
Topics Economy
News headline image
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics ↗
These businesses should see good times ahead. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
1 Brand-New (Good) Reason to Buy Viking Therapeutics Stock Now ↗
Its long-term growth potential looks like it's improving, again. 
Via The Motley Fool
News headline image
2 Potentially Explosive Stocks to Buy in April ↗
These two healthcare stocks should have plenty of room to run. 
Via The Motley Fool
News headline image
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market? ↗
Viking shares have soared recently on optimism about its program. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
Viking Therapeutics is preparing to be the next entry into the GLP-1 Market, and VKTX stock is soaring as analysts start to bid the stock higher 
Via MarketBeat
News headline image
5 Healthcare Stocks to Buy for 2024 ↗
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts ↗
With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets. 
Via InvestorPlace
News headline image
Tuesday Talk: April Is The Cruelest Month? ↗
At least that is what the poet T.S. Eliot wrote in the opening line of his well-known poem, 
Via Talk Markets
News headline image
Could Viking Therapeutics Stock Be a Millionaire Maker? ↗
There is a plausible path for this biotech stock to make some investors millionaires. 
Via The Motley Fool
News headline image
Russell 2000 Index Best And Worst Performing Stocks Of 2024 ↗
The Russell 2000 index continued to underperform the Dow Jones and Nasdaq 100 indices in the first quarter of 2024. 
Via Talk Markets
Topics Stocks
News headline image
The 3 Best Biotech Stocks to Buy in April 2024 ↗
Biotech is one of the hottest sectors on the market, creating big opportunities for some of the best biotech stocks to buy in April. 
Via InvestorPlace
News headline image
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst ↗
The company's experimental new weight-management drug looks great so far. 
Via The Motley Fool
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.